Markets

Insider Trading

Hedge Funds

Retirement

Opinion

15 Least Competitive Medical Specialties in America

In this article, we will look at the 15 least competitive medical specialities in America. We have also discussed the state of the healthcare industry in the US. If you want to skip our detailed analysis, head straight to the 5 Least Competitive Medical Specialities in America

Choosing a medical speciality involves a combination of factors like personal interest, aptitude, and the duration of training. Among primary care options, Family Medicine and Internal Medicine are generally considered easiest medical specialties to study, with relatively shorter residencies compared to some other specialities. Moreover, Emergency Medicine is the medical speciality that takes the least amount of time

It is also worth mentioning that programs in primary care specialities like Family Medicine, Internal Medicine, and Pediatrics are some of the easiest specialities to match into for International Medical Graduates (IMGs). On the other hand, Plastic Surgery, Dermatology, and Neurosurgery are the most competitive medical specialties in the US

Before getting into our list of the least competitive medical specialities in the US, let’s explore the current state of the healthcare industry in the US.  

State of Healthcare in the US

A recent Harris Poll revealed that over 70% of US adults believe the healthcare system is falling short of meeting their needs. Despite the US spending more per capita on healthcare than other developed countries, the survey of approximately 2,500 adults, conducted from February to March 2023, highlighted widespread dissatisfaction. More than half of respondents graded the US healthcare system a “C” or below, citing factors such as high costs (the most common criticism), profit-driven focus, insurance inaccessibility, and confusion about coverage. Notably, 44% admitted to skipping or delaying needed care in the past two years, with 40% attributing it to costs.

Interestingly, amid these challenges, the survey identified some positive sentiments. Over 75% of participants noted that providers collaborate to improve their health, 70% expressed a desire for stronger relationships with their healthcare providers, and more than 65% believed regular engagement with a trusted provider could improve their health. Despite frustrations, these responses suggest a nuanced perspective on the healthcare system’s potential improvement. However, these issues do not stop here.

A recent survey by the Commonwealth Fund also revealed alarming trends in American healthcare, with around 79 million Americans (41% working-age Americans) facing medical bill issues in the past year. Shockingly, this rate is the highest among nine developed countries analyzed. Even high-income Americans are almost as likely as lower-income individuals in other nations to defer healthcare due to costs, with 29% admitting to skipping or delaying care. This places the US at a disadvantage, especially considering that other developed countries with universal health coverage exhibit significantly lower rates of delayed or skipped care among high-income populations, ranging from 6% to 16%.

Companies Committed to Healthcare Access

As the fall and winter seasons approach, health officials are anticipating a challenging period with a potential increase in viral illnesses, including influenza, COVID-19, and Respiratory Syncytial Virus (RSV). Notably, the Centers for Disease Control and Prevention (CDC) has issued an important recommendation that allows adults aged 60 and older to receive an RSV vaccine if deemed appropriate by their healthcare provider. This is crucial in preventing severe respiratory infections in older adults and marks a positive development in combating RSV-related complications. 

McKesson Corp (NYSE:MCK), a major distributor of seasonal flu vaccines, is actively supporting the distribution and administration of vaccines targeting influenza, RSV, and the updated COVID-19 vaccines for the 2023-2024 season. Health Mart pharmacies, part of McKesson Corp (NYSE:MCK)’s network, are positioned as accessible and trusted healthcare providers that provide a destination for individuals to receive these vaccines as they become available in communities across the US.

In addition to addressing RSV concerns, McKesson Corp (NYSE:MCK) is also been active in the commercialization of COVID-19 vaccines. The company is handling the distribution of single-strain commercial vaccines from Pfizer Inc (NYSE:PFE), Moderna Inc (NASDAQ:MRNA), and Novavax, Inc (NASDAQ:NVXA) for the upcoming season. This involves direct purchase through wholesale distributors, similar to the distribution of flu vaccines, with McKesson Corp (NYSE:MCK) collaborating with vaccine manufacturers to meet customer demand and ensure proper storage conditions. 

On the other hand, as artificial intelligence has been at the forefront of industrial transformation , several healthcare companies have been exploring the potential of AI. Amgen Inc (NASDAQ:AMGN), a leading biotechnology company, has entered into a collaborative venture with Amazon Web Services, Inc (AWS), a subsidiary of Amazon.com, Inc. (NASDAQ:AMZN) to capitalize on generative AI for accelerating advanced therapies. This partnership aims to improve the discovery, development, and manufacturing throughput of medicines, catering to patients with serious illnesses.  Amgen Inc (NASDAQ:AMGN)’s collaboration with AWS extends beyond AI, incorporating the use of Amazon SageMaker for building, training, and deploying machine learning models. The companies are implementing cutting-edge digital and robotic technologies, which includes a connected digital platform on AWS, to optimize manufacturing processes at Amgen Inc (NASDAQ:AMGN)’s upcoming facility in Columbus, Ohio. This facility will feature real-time data analytics, predictive maintenance capabilities, and the integration of machine vision systems.

Moreover,  Amgen Inc (NASDAQ:AMGN) has also teamed up with PostEra for a major AI-driven drug discovery venture. In a deal worth $50 million upfront and $1.9 billion for successful outcomes,  Amgen Inc (NASDAQ:AMGN) and PostEra plan to advance up to five small molecule programs using PostEra’s AI platform.

A doctor and a scientist in a laboratory standing in front of a wall of medical equipment.

Our Methodology

In compiling our rankings of the least competitive medical specialities in America, we analyzed the National Residency Match Program (NRMP) outcomes for medical residency applicants. Our assessment primarily considered the average USMLE Step 1 scores of US seniors (MD/DO), arranging them in descending order.

In instances where average scores were identical, we further examined the scores of International Medical Graduate (IMG) applicants, both from the US and other countries. A lower average score for IMG applicants was given precedence. 

Here is a list of the least competitive medical specialities in America

15. Diagnostic Radiology

Average US Senior Score: 244

Diagnostic radiology is a medical specialty that uses imaging techniques such as X-rays, CT scans, and MRIs to diagnose and treat diseases. Radiologists interpret medical images to guide patient care. It is one of the least competitive residencies for International Medical Graduates (IMGs)

14. Vascular Surgery

Average US Senior Score: 244

Vascular surgery specializes in the diagnosis and treatment of diseases affecting the blood vessels, such as arteries and veins. The average salary for a Vascular Surgeon is $266774 per year 

13. Radiation Oncology

Average US Senior Score: 240

Radiation oncology is a medical speciality that employs ionizing radiation to treat cancer. Radiation oncologists use precise techniques to target and destroy cancer cells while minimizing damage to surrounding healthy tissues. It is one of the least competitive medical specialities in 2023. The average salary for a Radiation Oncologist is $167,029 per year 

12. Anesthesiology

Average US Senior Score: 236

Anesthesiology is a medical speciality focusing on perioperative patient care. The average salary for an Anesthesiologist is $318,500 per year in the United States. It is one of the highest-paid medical specialities in the world

11. General Surgery

Average US Senior Score: 235

General surgery is a medical speciality encompassing a broad range of surgical procedures. General surgeons diagnose, treat, and manage different conditions, performing surgeries on organs and tissues, excluding specific areas like the brain and heart. The average salary for a Surgeon is $298341 per year in the United States.

10. Internal Medicine

Average US Senior Score: 232

Internal medicine is a medical speciality focused on the prevention, diagnosis, and non-surgical treatment of adult diseases. Internal medicine is often considered one of the most underrated medical specialities. The average salary for an Internal Medicine Physician is $282992 per year in the United States.

9. Obstetrics and Gynaecology

Average US Senior Score: 231

Obstetrics and Gynaecology is a medical speciality dedicated to women’s reproductive health. Obstetricians manage pregnancies, childbirth, and postpartum care, while gynaecologists focus on the female reproductive system, addressing issues like menstrual disorders, infertility, and gynaecological cancers. Together, they provide comprehensive care for women throughout different stages of life. The average salary for an Obstetrician/Gynecologist is $212959 per year in the US. It is one of the best medical specialties for female doctors and moms.

8. Emergency Medicine

Average US Senior Score: 231

Emergency Medicine is a medical specialty that involves the prompt diagnosis and management of acute illnesses and injuries. The average salary for an Emergency Medicine Physician is $217226 per year in US. It is one of the top 10 least competitive medical specialities in America.

7. Neurology

Average US Senior Score: 230

Neurology is a medical speciality dedicated to the diagnosis and treatment of disorders affecting the nervous system. Neurologists focus on conditions such as epilepsy, stroke, multiple sclerosis, and neurodegenerative diseases. The average salary for a Neurologist is $253485 per year in United States.

6. Physical Medicine and Rehab

Average US Senior Score: 230

Physical Medicine and Rehabilitation (PM&R) is a medical specialty that aims to enhance and restore functional ability and quality of life for individuals with physical impairments or disabilities. The average Physical Medicine and Rehab Physician salary in the United States is $258,390. It is one of the least competitive residencies in America

Click here to see the 5 Least Competitive Medical Specialities in America.

Suggested Articles:

Disclosure: None. 15 Least Competitive Medical Specialities in America is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

  • The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
  • Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
  • Lifetime Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

  1. Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
  2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
  3. Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…